The Food and Drug Administration has kicked off an effort to use AI and other data science tools to monitor clinical trials in real time and cut down review times for new drugs. The agency announced the launch of two “proof of concept” real-time trials to view safety and efficacy signals for an AstraZeneca drug used to treat lymphoma and an Amgen drug for small cell lung carcinoma. Agency leaders portrayed the move as a major step toward keeping U.S. biomedical research competitive against countries like China.
Read the full article: FDA to Use AI to Track Clinical Trials in Real Time //
Source: https://www.axios.com/2026/04/29/fda-ai-track-clinical-trials-real-time